Is an autoimmune response exploding like the ‘Big Bang’ of the universe? Kazuhiko Yamamoto Invited Commentary Pages: 439 - 440
COX-2, NO, and cartilage damage and repair Ashok R. AminMandar DaveSteven B. Abramson OriginalPaper Pages: 447 - 453
Treatment of osteoarthritis with acetaminophen: Efficacy, safety, and comparison with nonsteroidal anti-inflammatory drugs Mohammed ShamoonMarc C. Hochberg OriginalPaper Pages: 454 - 458
Evidence of nutriceutical effectiveness in the treatment of osteoarthritis J. Y. ReginsterVincent GillotYves Henrotin OriginalPaper Pages: 472 - 477
Progress in systemic sclerosis: Novel therapeutic paradigms John Varga Clinical Trials Review Pages: 481 - 485
The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide Stephen J. Oliver OriginalPaper Pages: 486 - 491
Bone marrow transplantation in the treatment of systemic sclerosis Federico ViganegoRichard NashDaniel E. Furst OriginalPaper Pages: 492 - 500
Peripheral blood fibrocytes: Mesenchymal precursor cells and the pathogenesis of fibrosis Jason ChesneyRichard Bucala OriginalPaper Pages: 501 - 505
The promise of transcription profiling for understanding the pathogenesis of scleroderma David R. Strehlow OriginalPaper Pages: 506 - 511
The establishment and utility of a population-based registry to understand the epidemiology of systemic sclerosis Maureen D. Mayes OriginalPaper Pages: 512 - 516